{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06502964",
            "orgStudyIdInfo": {
                "id": "ALTO-101-201"
            },
            "organization": {
                "fullName": "Alto Neuroscience",
                "class": "INDUSTRY"
            },
            "briefTitle": "Study of ALTO-101 in Patients With Schizophrenia",
            "officialTitle": "Double-Blind, Placebo-Controlled Study of ALTO-101 in Patients With Schizophrenia and Cognitive Impairment",
            "therapeuticArea": [
                "Mental Health",
                "Other"
            ],
            "study": "study-of-alto-in-patients-with-schizophrenia"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-04",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-07",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-10",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-11",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-07-09",
            "studyFirstSubmitQcDate": "2024-07-09",
            "studyFirstPostDateStruct": {
                "date": "2024-07-16",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-15",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-17",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Alto Neuroscience",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": true,
            "isUnapprovedDevice": true
        },
        "descriptionModule": {
            "briefSummary": "This is a Phase 2, double-blind, placebo-controlled, two-way crossover study to compare the efficacy of ALTO-101T versus placebo in change in electroencephalogram (EEG) cognitive processing markers and measures of cognition.\n\nAdditional goals are to assess pharmacokinetic (PK), safety, and tolerability of the recently developed ALTO-101T transdermal delivery system (TDS) formulation in a patient population."
        },
        "conditionsModule": {
            "conditions": [
                "Schizophrenia",
                "Cognitive Impairment"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "CROSSOVER",
                "interventionModelDescription": "Each participant will receive both placebo and active study drug: 10-day administration each of placebo TDS and ALTO-101T TDS (in random order), with a 6- to 14-day washout period between conditions.",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 72,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "ALTO-101",
                    "type": "EXPERIMENTAL",
                    "description": "10 days administration of ALTO-101T transdermal delivery system (18-27 mg/day as a total of 6 patches/day)",
                    "interventionNames": [
                        "Drug: ALTO-101",
                        "Device: ALTO-101 Transdermal Delivery System"
                    ]
                },
                {
                    "label": "Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "10 days administration of placebo transdermal delivery system (with a total of 6 placebo patches/day)",
                    "interventionNames": [
                        "Drug: Placebo",
                        "Device: Placebo Transdermal Delivery System"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "ALTO-101",
                    "description": "4.5 mg ALTO-101 patches",
                    "armGroupLabels": [
                        "ALTO-101"
                    ]
                },
                {
                    "type": "DEVICE",
                    "name": "ALTO-101 Transdermal Delivery System",
                    "description": "4.5 mg ALTO-101 transdermal delivery system",
                    "armGroupLabels": [
                        "ALTO-101"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "Inactive placebo patches",
                    "armGroupLabels": [
                        "Placebo"
                    ]
                },
                {
                    "type": "DEVICE",
                    "name": "Placebo Transdermal Delivery System",
                    "description": "Placebo transdermal delivery system",
                    "armGroupLabels": [
                        "Placebo"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Theta band activity",
                    "description": "Theta band activity after 5 and 10 days of dosing of ALTO-101T compared to placebo.",
                    "timeFrame": "Treatment Period 1 - Day 6 and Day 11; Treatment Period 2 - Day 6 and Day 11"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability] ALTO-101T compared to placebo",
                    "description": "Incidence, severity, and relatedness of treatment-emergent adverse events (TEAEs), serious adverse events (SAEs), and discontinuation due to TEAEs.",
                    "timeFrame": "Treatment Period Day 1 through study completion (an average of 36 days)"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Schizophrenia diagnosis for at least one year\n* Cognitive impairment\n* Stable doses of 1-2 antipsychotic medication(s) for at least 8 weeks at Visit 2\n* Positive and Negative Syndrome Scale (PANSS) score: items P1, P3-P6 \u2264 5 and item P2 and P7 \u2264 4 during screening\n* Have a body mass index (BMI) \u2265 18.0 and \u2264 37.0 kg/m2 (inclusive)\n* Willing to comply with all study assessments and procedures\n\nExclusion Criteria:\n\n* Evidence of unstable medical condition\n* Acute psychiatric decompensation or severity of symptoms requiring psychiatric hospitalization in past 6 months\n* Diagnosis of schizoaffective or bipolar affective disorder, dementia, or intellectual disability\n* Current episode of major depressive disorder (MDD)\n* Use of mood stabilizer, clozapine, and/or daily benzodiazepine\n* Current moderate or severe substance use disorder",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "21 Years",
            "maximumAge": "55 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Alto Neuroscience",
                    "role": "CONTACT",
                    "phone": "650-200-0412",
                    "email": "clinical@altoneuroscience.com"
                }
            ],
            "locations": [
                {
                    "facility": "Site 5083",
                    "status": "RECRUITING",
                    "city": "Garden Grove",
                    "state": "California",
                    "zip": "92845",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Clinical Operations Manager",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.77391,
                        "lon": -117.94145
                    }
                },
                {
                    "facility": "Site 5060",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Hollywood",
                    "state": "Florida",
                    "zip": "33024",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Clinical Operations Manager",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 26.0112,
                        "lon": -80.14949
                    }
                },
                {
                    "facility": "Site 5056",
                    "status": "RECRUITING",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60640",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Clinical Operations Manager",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                },
                {
                    "facility": "Site 5062",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Gaithersburg",
                    "state": "Maryland",
                    "zip": "20877",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Clinical Operations Manager",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.14344,
                        "lon": -77.20137
                    }
                },
                {
                    "facility": "Site 5055",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Cedarhurst",
                    "state": "New York",
                    "zip": "11516",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Clinical Operations Manager",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.62288,
                        "lon": -73.7243
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000012559",
                    "term": "Schizophrenia"
                },
                {
                    "id": "D000060825",
                    "term": "Cognitive Dysfunction"
                }
            ],
            "ancestors": [
                {
                    "id": "D000019967",
                    "term": "Schizophrenia Spectrum and Other Psychotic Disorders"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                },
                {
                    "id": "D000003072",
                    "term": "Cognition Disorders"
                },
                {
                    "id": "D000019965",
                    "term": "Neurocognitive Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M29705",
                    "name": "Cognitive Dysfunction",
                    "asFound": "Cognitive Impairment",
                    "relevance": "HIGH"
                },
                {
                    "id": "M15376",
                    "name": "Schizophrenia",
                    "asFound": "Schizophrenia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M21838",
                    "name": "Schizophrenia Spectrum and Other Psychotic Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M6301",
                    "name": "Cognition Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M21836",
                    "name": "Neurocognitive Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}